Hexin Instrument (688622) 2023 Third Quarter Report Review: Revenue increased year-on-year, bright medical products continued to advance
光大證券Nov 8, 2023 00:00
Hexin Instrument (688622) 2023 third quarter report review: Domestic mass spectrometry technology leads the third quarter, losses narrowed markedly
國元證券Nov 3, 2023 07:32
Hexin Instruments (688622): Core key technology is autonomous and controllable to help replace domestic production
國元證券Sep 4, 2023 00:00
Hexin Instrument (688622) 2022 Annual Report and 2023 Quarterly Report Reviews: Short-term fluctuations in 2022 operations and market recovery in the first quarter led to a recovery in revenue
光大證券Apr 29, 2023 00:00
Hexin Instrument (688622) 2022 Third Quarter Report Review: Revenue Fluctuates Due to the Impact of the Pandemic, Interest Rate Loans Help the Company Release Instruments
光大證券Oct 31, 2022 00:00
Hexin Instruments (688622): Decline in gross margin drags down improvements in profit product structure
廣發證券Apr 28, 2022 21:07
N Hexin (688622): “Specializing in Special and New” Little Giants as Chinese Mass Spectrometry Instruments
安信證券Sep 14, 2021 00:00
N Hexin (688622): The multi-point layout of domestic mass spectrometer leaders is waiting to blossom
廣發證券Sep 12, 2021 00:00
No Data
No Data